Womble Bond Dickinson’s Regulatory Affairs Leads FDA Discussions at Winston-Salem’s Venture Café Thursday Gathering
Nov 22 2019
WINSTON-SALEM, NC— The weekly Venture Café Winston-Salem Thursday Gathering serves as a physical nexus for helping innovators and entrepreneurs find one another and collaborate to bring their dreams to reality. Womble Bond Dickinson is proud to be a Thought Leader sponsor of Venture Café Winston-Salem and was delighted to lead sessions to educate North Carolina Piedmont innovators, entrepreneurs and local businesses on how to navigate The Food and Drug Administration (“FDA”), a mission-critical step in taking new products to market.
On Thursday, November 14, Martika Harper and Dr. Heather Hatcher along with Rolf Garcia-Gallont and Mark Vaders presented two informative sessions on FDA-related topics:
Heather Hatcher is leading the firm’s participation in the Venture Café. The Thursday Gatherings take place in Winston-Salem’s Bailey Power Plant, a former industrial facility that has been refurbished as a multi-use space.
Stay tuned for more Womble Bond Dickinson programming at the January 16, 2020 Venture Café Thursday Gathering session.
Venture Café Winston-Salem helps enhance and accelerate the growth of innovation and entrepreneurship in our city through high-impact programming and events and by creating intentional spaces for individuals and organizations to gather, connect, and build relationships.
Womble Bond Dickinson’s FDA Regulatory Affairs Team has years of experience at the FDA as well as scientific and technical knowledge to provide strategic regulatory guidance to clients in the pharmaceutical, biotechnology, and medical device industries. We offer scalable solutions to the full range of issues facing regulated medical products, including cutting-edge products like biosimilars, cell and gene therapies, 3D printed combination products, precision medicine and in vitro diagnostics. We also have regulatory experience with dietary supplements, food, cosmetics, and veterinary products.